Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| 1 |
American Tower
AMT
|
+$459M |
| 2 |
Equinix
EQIX
|
+$253M |
| 3 |
Consolidated Edison
ED
|
+$204M |
| 4 |
Xcel Energy
XEL
|
+$194M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$177M |
Top Sells
| 1 |
Crown Castle
CCI
|
+$394M |
| 2 |
Apple
AAPL
|
+$331M |
| 3 |
CSX Corp
CSX
|
+$253M |
| 4 |
Cheniere Energy
LNG
|
+$217M |
| 5 |
Welltower
WELL
|
+$213M |
Sector Composition
| 1 | Technology | 19.39% |
| 2 | Healthcare | 15.06% |
| 3 | Financials | 12.38% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Energy | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSVT
1926
DELISTED
2seventy bio
TSVT
| $949K | ﹤0.01% |
65,185
-4,323
| -6% | -$62.9K |
|
|
RWT
1927
Redwood Trust
RWT
$804M
| $947K | ﹤0.01% |
164,967
-32,735
| -17% | -$188K |
|
1928
Celldex Therapeutics
CLDX
$1.62B
| $942K | ﹤0.01% |
33,512
-136,702
| -80% | -$3.84M |
|
1929
Columbia Banking Systems
COLB
$7.8B
| $942K | ﹤0.01% |
32,608
-10,566
| -24% | -$305K |
|
1930
Integral Ad Science
IAS
$1.4B
| $936K | ﹤0.01% |
129,337
+110,729
| +595% | +$801K |
|
1931
Axcelis
ACLS
$2.69B
| $932K | ﹤0.01% |
15,386
-3,197
| -17% | -$194K |
|
1932
NETSCOUT
NTCT
$1.8B
| $931K | ﹤0.01% |
29,701
-7,742
| -21% | -$243K |
|
1933
Hercules Capital
HTGC
$3.53B
| $930K | ﹤0.01% |
80,294
+2,568
| +3% | +$29.7K |
|
1934
Editas Medicine
EDIT
$242M
| $929K | ﹤0.01% |
75,944
-44
| -0.1% | -$538 |
|
|
ELME
1935
Elme Communities
ELME
$1.51B
| $925K | ﹤0.01% |
52,696
-9,916
| -16% | -$174K |
|
1936
Cavco Industries
CVCO
$4.32B
| $924K | ﹤0.01% |
4,490
-982
| -18% | -$202K |
|
1937
iShares Core S&P Small-Cap ETF
IJR
$85.7B
| $921K | ﹤0.01% |
10,551
-1,306
| -11% | -$114K |
|
1938
Palomar
PLMR
$3.13B
| $921K | ﹤0.01% |
11,000
-2,838
| -21% | -$238K |
|
1939
RLX Technology
RLX
$3.18B
| $921K | ﹤0.01% |
877,958
-60,804
| -6% | -$63.8K |
|
1940
First Merchants
FRME
$2.31B
| $920K | ﹤0.01% |
23,791
-6,143
| -21% | -$238K |
|
1941
Blackbaud
BLKB
$3.38B
| $918K | ﹤0.01% |
20,845
-4,983
| -19% | -$219K |
|
1942
J&J Snack Foods
JJSF
$2.02B
| $915K | ﹤0.01% |
7,068
-1,513
| -18% | -$196K |
|
1943
Cartesian Therapeutics
RNAC
$252M
| $914K | ﹤0.01% |
18,576
+85
| +0.5% | +$4.18K |
|
1944
Bruker
BRKR
$4.69B
| $912K | ﹤0.01% |
17,182
-3,630
| -17% | -$193K |
|
|
GOGL
1945
DELISTED
Golden Ocean Group
GOGL
| $911K | ﹤0.01% |
122,015
-12,729
| -9% | -$95K |
|
1946
Sabre
SABR
$738M
| $909K | ﹤0.01% |
176,471
-30,202
| -15% | -$156K |
|
1947
Envista
NVST
$3.49B
| $908K | ﹤0.01% |
27,695
-20,890
| -43% | -$685K |
|
1948
Quaker Houghton
KWR
$2.46B
| $899K | ﹤0.01% |
6,227
-1,277
| -17% | -$184K |
|
1949
PagerDuty
PD
$1.53B
| $899K | ﹤0.01% |
38,981
-8,360
| -18% | -$193K |
|
1950
AC Immune
ACIU
$244M
| $898K | ﹤0.01% |
284,043
| – | – |
|